Methotrexate is a widely-used drug in autoimmunity diseases, such as RA, and inhibits dihydrofolate reductase (DHFR) and decreases glycolysis and ATP levels, and so is used in RA, CD, psoriasis [207], and MS [209]. Here, DHFR is linked to myeloid sarcoma.